Excedrin
This article was originally published in The Tan Sheet
Executive Summary
Bristol-Myers Squibb launches TV ad in July touting Extra Strength Excedrin as "the headache medicine." Created by New York- based Bozell, the spot maintains that medical research shows that Excedrin is "better" for headaches. The ad features a woman advising consumers that they should not give up McNell's Tylenol for fever, but suggests that headache sufferers should take Excedrin. A Sept. 12 FSI also emphasizes the product's "headache medicine" theme. BMS recently reassigned advertising for three of its Excedrin products from DDB Needham, New York, with Bozell picking up the Extra Strength Excedrin and Aspirin-Free Excedrin accounts ("The Tan Sheet" July 12, In Brief).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning